Editas Medicine, Inc. (EDIT)
NASDAQ: EDIT · Real-Time Price · USD
2.300
-0.050 (-2.13%)
Oct 19, 2026, 12:04 PM EDT - Market open
Editas Medicine Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Buy Upgrades $6 | Buy | Upgrades | $6 | +160.87% | Oct 8, 2026 |
| Guggenheim | Guggenheim | Buy Upgrades $5 | Buy | Upgrades | $5 | +117.39% | Sep 23, 2026 |
| Ladenburg Thalmann & Co. | Ladenburg Thalmann & Co. | Buy Initiates $6 | Buy | Initiates | $6 | +160.87% | Aug 18, 2026 |
| Bank of America Securities | Bank of America Securities | Sell Reiterates n/a | Sell | Reiterates | n/a | n/a | Aug 7, 2026 |
| RBC Capital | RBC Capital | Hold Maintains $4 | Hold | Maintains | $4 | +73.91% | Aug 6, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $3 → $5 | Buy | Reiterates | $3 → $5 | +117.39% | Aug 6, 2026 |
| TD Cowen | TD Cowen | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Aug 6, 2026 |
| JonesTrading | JonesTrading | Buy Maintains $8 | Buy | Maintains | $8 | +247.83% | Aug 6, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.